Sight Sciences (SGHT) Net Income towards Common Stockholders (2020 - 2026)
Sight Sciences (SGHT) posted quarterly Net Income towards Common Stockholders of -$13.0 million for Q1 2026, up 8.29% year-over-year from -$12.0 million in Q1 2025, and down 211.87% quarter-over-quarter from -$4.2 million in Q4 2025.
Sight Sciences (SGHT) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends
Sight Sciences' Net Income towards Common Stockholders history runs 7 years deep, the most recent figure standing at -$13.0 million for Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders rose 8.29% year-over-year to -$13.0 million; the TTM figure through Mar 2026 stood at -$37.3 million (up 24.58% YoY), while the FY2025 annual figure was -$38.4 million, up 25.4% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$13.0 million, down from -$4.2 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was -$4.2 million in Q4 2025, with the low at -$23.8 million in Q2 2022.
- The 5-year median for Net Income towards Common Stockholders is -$13.0 million (2023), against an average of -$14.4 million.
- The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders sank 90.06% in 2022, then soared 64.87% in 2025.
- Sight Sciences' Net Income towards Common Stockholders stood at -$16.9 million in 2022, then surged by 36.77% to -$10.7 million in 2023, then declined by 10.8% to -$11.8 million in 2024, then jumped by 64.87% to -$4.2 million in 2025, then slumped by 211.87% to -$13.0 million in 2026.
- Business Quant data shows SGHT's Net Income towards Common Stockholders at -$13.0 million in Q1 2026, -$4.2 million in Q4 2025, and -$8.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Sight Sciences | 453.49 Mn | 373.74 Mn | 21.37 Mn | -4.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.45 Mn |
| Mar 31, 2026 | -12.98 Mn |
| Dec 31, 2025 | -4.16 Mn |
| Sep 30, 2025 | -8.17 Mn |
| Jun 30, 2025 | -11.94 Mn |
| Mar 31, 2025 | -14.15 Mn |
| Dec 31, 2024 | -11.85 Mn |
| Sep 30, 2024 | -11.07 Mn |
| Jun 30, 2024 | -12.33 Mn |
| Mar 31, 2024 | -16.27 Mn |
| Dec 31, 2023 | -10.69 Mn |
| Sep 30, 2023 | -13.04 Mn |
| Jun 30, 2023 | -14.75 Mn |
| Mar 31, 2023 | -17.07 Mn |
| Dec 31, 2022 | -16.91 Mn |
| Sep 30, 2022 | -22.23 Mn |
| Jun 30, 2022 | -23.84 Mn |
| Mar 31, 2022 | -23.26 Mn |
| Dec 31, 2021 | -15.94 Mn |
| Sep 30, 2021 | -17.17 Mn |